Introduction: The anti-infective effect of early colonization of infants by potentially probiotic lactic acid bacteria in human milk is a growing area of research. Lactobacillus plantarum colonization in early infancy may be important to health in later life. Here, we present an investigation into the presence of L. plantarum in breast milk from Iranian mothers. Materials and Methods: Human breast milk samples (n = 40) were randomly collected from lactating and breastfeeding women having undergone full-term pregnancies. Information concerning personal characteristics was collected after birth. The samples were cultured in de Man, Rogosa, and Sharpe medium using the pour plate technique, and isolates were initially identified by biochemical methods. Isolates were established as belonging to the genus Lactobacillus based on the 16-23S rRNA region, and the species L. plantarum was identified using PCR and primers targeting the recA gene. Results: In our study, 35 samples (87.5%) contained suspected lactobacilli based on phenotypic tests. Thirty of these (85.71%) were confirmed as containing bacteria of the genus Lactobacillus using a genotypic method (PCR), all of which were found to be L. plantarum. Conclusion: Probiotic bacteria in a mother's breast milk may have positive effects on her infant's health. This insight creates new perspectives concerning the use of breast milk as a source of probiotic bacteria for bacteriotherapy.
Introduction
The nutritional qualities of breast milk have developed since the divergence of mammals [1] . Breast milk includes several functional nutrients that facilitate the creation of a microenvironment optimized for gut development and maturation [2, 3] . Some of these components, including regulatory cytokines and growth factors, also exert a protective effect. In addition, breast milk contains several variable components, such as lysozyme, lactoferrin, and oligosaccharides, which contribute to the prevention of infections and support the growth of beneficial bacteria in the gut. Furthermore, breast milk represents a continuous supply of microbes, factors favoring their growth, and components that regulate host-microbe interactions. These properties emphasize one of the key functions of breastfeeding in conferring protection on newborn children during a critical period in their life, when breast milk is their principal source of nutrition and their own immune defenses, such as the integrity of the gastrointestinal tract (GIT) barrier, are immature [4] [5] [6] [7] .
It has recently been accepted that consumption of breast milk is a means by which newborns obtain microorganisms that may colonize their gut and modulate its function [8] [9] [10] [11] [12] . Several bacteria predominate in human breast milk, including staphylococci, streptococci, micrococci, lactobacilli, enterococci, lactococci, and bifidobacteria [8, 13, 14] . These bacteria, which are present in the breast, originate from the maternal intestines and reach the mammary glands through an endogenous route, via macrophages and dendritic cells [15, 16] . Thus, breastfeeding may be a significant source of lactobacilli, along with other probiotic species, for the newborn gut. The Lactobacillus genus contains more than 25 varieties of gram-positive, catalasenegative, and rod-shaped bacteria, which constitute less than 1% of all intestinal bacteria in adults. However, members of this genus make up a greater proportion of the neonatal and infant intestinal microflora (between 10 5 and 10 8 CFU/g of feces) [17, 18] . The lactobacilli species isolated from breast milk to date are
. crispatus, and L. salivarius [8, 14, 16, 19] .
There is increasing evidence that some probiotic strains exert preventive and/or curative effects on a range of infections and inflammatory gastrointestinal infectious diseases [20] [21] [22] . The survival capacity (acid and bile salt tolerance, survival in a simulated GIT, pathogen inhibition, antibiotic susceptibility, and exopolysaccharide production) and probiotic properties (reduction of pathogen adhesion and protection of Caco-2 cells from the effect of sodium dodecyl sulfate and inflammatory stress) of a specific strain of Lactobacillus plantarum isolated from human breast milk have been investigated in previous work [23] . Lactobacilli constitute an essential component of the healthy human intestinal microbiota and are believed to be involved in its control and maintenance [24] .
L. plantarum is a versatile lactic acid bacterium with a proven ability to survive gastric transit and colonize the intestinal tracts of humans and other mammals [25] . An increasing number of studies have; addressed the possibility of developing an ingestible living vaccine using L. plantarum [26] . Furthermore, work is ongoing to determine the activity of this bacterium, which has previously been found in breast milk from women in other countries, in the human intestinal tract [11, 27, 28] . The consumption of L. plantarum has been associated with significant health improvements in humans and other animals [29] [30] [31] [32] . In in vitro and in vivo tests of the beneficial health effects of probiotics, an L. plantarum strain was found to have an adequate safety profile, a strong ability to survive in the GIT, and positive effects on hosts [33, 34] . L. plantarum has also been used in human clinical trials for its promotion of the immune system and alleviation of intestinal disorders and cardiovascular diseases [35, 36] . Supplementation with probiotic L. plantarum IS-10506 and zinc for 90 days was found to result in a significantly increased humoral immune response, as well as improved zinc status, in young children [37] . Moreover, there is growing evidence that lactobacilli colonization at a very early age may protect infants from developing atopic allergy [38] . In addition, administration of a Lactobacillus strain from human milk to infants for 6 months has been shown to lead to 46%, 27%, and 30% reductions in the incidence of gastrointestinal, upper respiratory tract, and total infections, respectively [39] . The aim of the present study was to contribute to the investigation of the presence of beneficial bacteria from healthy sources, such as breast milk, in Iran.
Materials and Methods

Samples and data collection
Breast milk samples (n = 40) were randomly collected from lactating mothers having undergone full-term pregnancies and with breastfed infants aged 3 days to 12 months. All volunteers provided written informed consent to participate in the study, which was approved by the Ethics Committee of Isfahan University of Medical Sciences. Information regarding personal characteristics, dietary habits, and the infants (including details of delivery and early infant feeding) were collected after birth. Data concerning the duration of breastfeeding and infant feeding practices were recorded during interviews [19] .
Clinical evaluation and exclusion criteria (subjects and design)
All volunteers were informed of the aim and protocol of the investigation. Subjects with fever, diabetes, infections, metabolic disease, gestational hypertension, diseases of the breast or central nervous system, malnutrition, maternal allergy, or addictions and those drinking alcohol were excluded, as were newborns with any malformation or cardiac or hemolytic disease. Diseases were diagnosed from subjects' medical histories and by physical examination. All participants were healthy and without any infant and/or maternal perinatal problems. Only healthy women who had not used antibiotics within the 2 weeks prior to the study were included. The participating mothers avoided consumption of any herbal tea and supplements containing lactic acid bacteria (LAB) for 2 weeks before sampling. There were no other restrictions to their normal diet, which may have contained naturally occurring LAB. The mothers were between 18 and 40 years of age. They refrained from breastfeeding 1 h before providing a sample, which was taken in the morning [38] . 
Sampling
The nipple and mammary areola were cleaned with soap and sterile water, before application of chlorhexidine (Qiagen, Hilden, Germany). The breast milk sample (10-15 ml) was collected in a sterile tube using sterile gloves. The first drops (approximately 1 ml) were discarded to avoid chlorhexidine contamination. Similarly, a swab from the nipple and mammary areola were obtained to assess the efficacy of the antiseptic treatment. The tubes containing the samples were packed in insulated boxes containing dry ice and sent to the laboratory within two hours [40] .
Isolation and identification of bacteria
Aliquots (1000 µl) of the samples were plated directly for culture. In addition, serial dilutions were plated on 3 culture plates using the pour plate method with de Man, Rogosa, and Sharpe (MRS) medium (Merck, Darmstadt, Germany). This was performed in duplicate, and the medium was supplemented with 0.5% glucose (Merck) and 0.25% l-cysteine (Merck) to select for LAB and favor the growth of lactobacilli. The agar plates were incubated at 37 ∘ C under anaerobic conditions (10% H 2 , 10% CO 2 , and 80% N 2 ) in a Mac 500 chamber (Mart Microbiology, Lichtenvooorde, Netherlands) for 48-72 h. Suspected LAB colonies were purified by streaking on appropriate media. Colonies were then counted and selected for further tests. The identity of the isolates was confirmed by Gram staining, microscopic examination, and catalase and oxidase reactions. PCR amplification of the genomic DNA of the isolated bacteria was performed to determine the genus and species [41] .
Genomic DNA preparation
Genomic DNA was obtained as follows: a 10-ml overnight culture of bacteria was pelleted by centrifugation (3023 ×g for 10 min at 4 ∘ C), washed twice in phosphatebuffered saline (pH 7.2), and suspended in 400 µl of lysis buffer (2.5 mg.ml One microliter of diluted DNA was used as a template for PCR. The positive controls comprised DNA extracted from L. plantarum subsp. plantarum PTCC1745 (prepared by the Persian Type Culture Collection). The negative controls consisted of Escherichia coli DNA extracts (prepared by the Department of Microbiology, Faculty of Medicine, Isfahan University of Medical Sciences). DNA extraction was performed as described above [42] .
PCR Analysis
PCR amplification of the 16S-23S rRNA region and flanking 23S rRNA gene
To confirm that isolates belonged to the genus Lactobacillus, they were selected from MRS medium and subjected to 16S rRNA gene sequence analysis using PCR. Amplification of the 16S rRNA gene was performed using the following primer pair: forward, 5′-GCT GGA TCA CCT CCT TTC-3′; and reverse, 5′-CCT TTC CCT CAC GGT ACT G-3′. 
Identification of L. plantarum
To identify L. plantarum among the Lactobacillus isolates, the extracted DNA was subjected to PCR using forward (5′- 
Results
Culture and PCR-based detection of specific genes
Of the 40 mothers that participated in this study, 35 (87.5%) had lactobacilli in their breast milk. The minimum, maximum, and median log10 bacterial counts in the breast milk of the positive mothers were 1.55, 5.04, and 3.18 cells⋅ml −1 , respectively, considering all oxidase-and catalase-negative, gram-positive, and rod-shaped bacteria. Table 1 shows the characteristics of the studied mothers.
Amplification of the 16S rRNA gene using genus-specific primers and PCR (yielding an amplicon of 700-800 bp) (Figure 1) , followed by homology analysis with the Basic Local Alignment Search Tool (BLAST), revealed that 30 (85.71%) of the isolates belonged to the genus Lactobacillus. PCR amplification of the recA gene using speciesspecific primers (resulting in a 319-bp product) (Figure 2 ), followed by a BLAST homology search, revealed all of the Lactobacillus isolates to be L. plantarum.
Discussion
This study represents the first attempt to determine the presence of L. plantarum in human breast milk in Iran. Breast milk is not sterile, even when collected in an aseptic manner; therefore, it likely harbors a natural bacterial inoculum that influences colonization of the neonatal GIT. Breast milk not only provides a variety of substrates for bacterial growth [45] , but is also a significant source of LAB that appear to be of endogenous origin rather than contaminants from breast skin 8-10. The presence of lactobacilli in breast milk has been associated with that of prebiotic oligosaccharides in this same fluid [46] [47] [48] . In the present study, even though no supplements or foods containing probiotics or prebiotics were given to the participants, the breast milk collected contained strains of L. plantarum, the first time such bacteria have been found in breast milk in Iran. [51] . Based on this information, breast milk has been proposed as a good source of potentially probiotic LAB. Moreover, it can be considered a natural symbiont-containing food harboring a combination of probiotics and prebiotics that may ultimately foster a specific "healthy" microbiota in the infant gut [52, 53] .
Lactobacilli strains in human milk contribute to infant digestion through the breakdown of sugars and proteins and are metabolically active in the infant gut, resulting in increased production of functional metabolites such as butyrate, the main energy source of colonocytes and a compound considered relevant to the modulation of intestinal function. Importantly, such bacteria also improve intestinal habits, increasing fecal moisture content and stool frequency and volume [54, 55] . They also contribute to reducing the incidence and severity of infections in breastfed infants by several mechanisms, such as competitive exclusion, production of antimicrobial compounds, and improvement of intestinal barrier function by raising mucin production and reducing intestinal permeability [9, 10, 13, 56] . As a result, and as the rate of infectious diseases is significantly lower among breastfed infants than formula-fed infants, anti-infective properties have been attributed to breast milk [57] .
Thus, lactobacilli from breast milk are excellent candidates for the development of infant probiotic products [56] . The isolation of probiotic bacteria from human milk could clearly be employed to benefit the intestinal microbiota and immune development of infants who, for various reasons, cannot be breastfed [57] . Indeed, there is evidence indicating that some strains isolated from breast milk demonstrate good probiotic potential, favoring their inclusion in products targeted at infants [49] . Modulation of the maternal intestinal microbiota can have a direct effect on an infant's health, offering new perspectives on bacteriotherapy, which may be used as an effective alternative to antibiotics. Work is in progress to elucidate the mechanisms responsible for such effects [38] . The potential role of the microbiome in human milk appears to have implications for not only short-and long-term infant health, but also mammary health. A better understanding of the link between the milk microbiome and health, as well as other potential factors influencing this association, will open new avenues in the study of pregnancy and lactation [58, 59] . Further research is needed to better understand the associations between health status and actual microbial communities, as well as their possible beneficial impacts on both mothers and their infants. Human milk could be a good and safe source of probiotic bacteria capable of improving the infant intestinal microflora.
Conclusion
L. plantarum is present in the human milk. It is found in a minority of nursing mothers but in geographically distant countries. Further studies are needed to provide a better understanding of the significance of this organism and other LAB in breast milk and their relevance to infant and maternal health. This study supports the use of isolated breast milk probiotics in the development of new pharmaceutical preparations, as supplements in the food industry, and in functional foods to benefit public health. Their inclusion in formula milk would be advantageous for infants not receiving breast milk.
